Aethlon Medical (AEMD) Misses Q3 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts AEMD Hot Sheet
Price: $5.63 -2.93%
Financial Fact:
General and administrative: 290.13K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
General and administrative: 290.13K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Aethlon Medical (NASDAQ: AEMD) reported Q3 EPS of ($0.16), $0.03 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $17.1 thousand versus the consensus estimate of $260 thousand.
For earnings history and earnings-related data on Aethlon Medical (AEMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CPS Technologies (CPSH) Reports In-Line Q3 EPS
- McDonald's posts better-than-expected third-quarter comparable sales
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
